imipenem, anhydrous has been researched along with Cronobacter Infections in 122 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (5.74) | 18.7374 |
| 1990's | 15 (12.30) | 18.2507 |
| 2000's | 30 (24.59) | 29.6817 |
| 2010's | 60 (49.18) | 24.3611 |
| 2020's | 10 (8.20) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| André, C; Arpin, C; Coulange, L; Couture, JF; Doermann, HP; Dubois, V; Ducastaing, A; Dutilh, B; Fischer, I; Fourmaux, S; Grobost, F; Jullin, J; Lagrange, I; Noury, P; Quentin, C | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Castanheira, M; Deshpande, LM; Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Espedido, BA; Iredell, JR; Partridge, SR | 1 |
| Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
| Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M | 1 |
| Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY | 1 |
| Bernabeu, S; Berthelot, P; Carricajo, A; Nordmann, P; Poirel, L; Pozzetto, B; Ros, A | 1 |
| Chang, H; Liu, CP; Sun, FJ; Wang, NY; Wu, AY | 1 |
| Chen, S; Fu, P; He, L; Li, C; Luo, X; Rong, H; Shen, J; Wang, A; Wang, C; Zhang, L | 1 |
| Bush, K; Campbell, A; Carpenter, J; Fortney, T; Neidig, N; Thornsberry, T; Truex, T; Zhang, Y | 1 |
| Hsueh, PR; Jean, SS | 1 |
| Bogiel, T; Gospodarek-Komkowska, E; Sêkowska, A; Woźniak, M | 1 |
| Aboklaish, AF; Brem, J; Jackson, DE; Langley, GW; Schofield, CJ; Tselepis, L; Tyrrell, JM; Walsh, TR; Widlake, E | 1 |
| Eda, R; Kitasato, H; Maehana, S; Nakamura, M; Nakano, R; Takayama, Y; Yano, H | 1 |
| He, Y; Lei, JE; Li, F; Lin, Y; Ma, C; Wang, Q; Xu, JR | 1 |
| Funashima, Y; Miyamoto, H; Nagasawa, Z; Oho, M; Sueoka, E | 1 |
| Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K | 1 |
| Adam, HJ; Baxter, MR; Golden, A; Karlowsky, JA; Lagace-Wiens, P; Walkty, A; Zhanel, GG | 1 |
| Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
| Hong, YK; Ko, KS; Lee, H; Lee, JY | 1 |
| Ito-Horiyama, T; Kanazawa, S; Kohira, N; Sato, T; Tsuji, M; Yamano, Y | 1 |
| Chanawong, A; Charoensri, N; Daduang, J; Lulitanond, A; Srisrattakarn, A; Wilailuckana, C | 1 |
| Barraja, P; Carbone, A; Cascioferro, S; Cirrincione, G; Diana, P; Montalbano, A; Parrino, B; Schillaci, D; Spanò, V | 1 |
| Bernabeu, S; Dortet, L; Gonzalez, C; Naas, T | 1 |
| Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
| Bush, K; Kashikar, A; Zhang, Y | 1 |
| Akamatsu, N; Hasegawa, H; Kaku, N; Kawamoto, Y; Kosai, K; Matsuda, J; Morinaga, Y; Uno, N; Yamakawa, H; Yanagihara, K | 1 |
| Amin, M; Dibachi, S; Shahin, M | 1 |
| Barguellil, F; Ben Helal, R; Ben Moussa, M; Chedly, M; Dziri, R; El Asli, MS; Klibi, N | 1 |
| Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
| Akeda, Y; Hamada, S; Ishihara, T; Sakamoto, N; Shanmugakani, RK; Shintani, A; Sugawara, Y; Takeuchi, D; Tomono, K; Yamamoto, N | 1 |
| Callan, K; Canver, MC; Chen, L; Fauntleroy, K; Jenkins, SG; Kreiswirth, BN; La Spina, M; Robertson, A; Satlin, MJ; Westblade, LF | 1 |
| Burgess, DS; Kulengowski, B | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 2 |
| Hächler, H; Hofer, E; Nüesch-Inderbinen, MT; Sarno, E; Stephan, R | 1 |
| Kasahara, K; Koizumi, A; Komatsu, Y; Mikasa, K; Mizuno, F; Nakayama, A; Ui, K | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Hayakawa, K; Kirikae, T; Kubota, S; Kuroda, E; Kutsuna, S; Mezaki, K; Miyoshi-Akiyama, T; Nagamatsu, M; Ohmagari, N; Shimada, K; Sugiki, Y; Takeshita, N; Tojo, M | 1 |
| Alves, M; Bige, N; Canoui, E; Offenstadt, G; Tankovic, J | 1 |
| Bertrand, X; Cabrolier, N; Hocquet, D; Manzoni, M; Sauget, M | 1 |
| Barth, AL; Nodari, CS; Ribeiro, VB | 1 |
| Chen, Z; Li, L; Sun, Z; Tian, L; Wang, Y; Yan, S; Zhang, B; Zhu, X | 1 |
| Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS | 1 |
| Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
| Adachi, Y; Nihonyanagi, S; Okamoto, R; Takayama, Y | 1 |
| Troncoso C, P; Vera A, N; Zwanzger M, C | 1 |
| Claverie, JM; Davin-Régli, AV; Maigre, L; Masi, M; Pagès, JM; Philippe, N; Pinet, E; Santini, S | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Chen, G; Cheng, J; Hu, L; Li, J; Liu, Y; Yang, H; Ye, Y | 1 |
| Chanawong, A; Charoensri, N; Lulitanond, A; Piyapatthanakul, S; Srisrattakarn, A; Supajeen, A; Wilailuckana, C; Wonglakorn, L | 1 |
| Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT | 1 |
| Arcilla, MS; Bootsma, MC; de Jong, MD; Goorhuis, A; Grobusch, MP; Melles, DC; Molhoek, N; Oude Lashof, AM; Penders, J; Schultsz, C; Stobberingh, EE; van Genderen, PJ; van Hattem, JM; Verbrugh, HA | 1 |
| Chang, CL; Huang, YC; Lee, CT; Mao, YC; Su, LH | 1 |
| Barbeyto, LP; Bou, G; Oviaño, M; Ramírez, CL | 1 |
| Kayama, S; Ohge, H; Sugai, M | 1 |
| Hackel, MA; Hoban, DJ; Karlowsky, JA; Kazmierczak, KM; Lob, SH; Motyl, MR; Sahm, DF; Young, K | 1 |
| Chen, YG; Li, LJ; Qu, TT; Shen, P; Wei, ZQ; Yu, YS; Zhang, Y | 1 |
| Patterson, JE | 1 |
| Alba, J; Belmonte, O; Drouet, D; Jaffar-Bandjee, MC; Kuli, B; Lugagne-Delpon, N; Moiton, MP; Mourlan, C | 1 |
| Castanheira, M; Jones, RN; Sader, HS | 1 |
| Cantón, R; García, A; Gimeno, C; Gobernado, M | 1 |
| Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H | 1 |
| Du, X; Jiang, X; Li, G; Wang, Y; Wei, Q; Zhao, Y | 1 |
| Adamou, P; Antoniadou, A; Galani, I; Giamarellou, H; Panagea, T; Souli, M | 1 |
| Benenson, S; Block, C; Cohen, MJ; Hidalgo-Grass, C; Schwartz, C; Temper, V | 1 |
| Agodi, A; Koumaki, V; Poulou, A; Pournaras, S; Sofianou, D; Themeli-Digalaki, K; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
| Kim, J; Kim, S; Kim, SM; Lee, HW; Seol, SY | 1 |
| Bourg, G; Bouziges, N; Davin-Regli, A; Lavigne, JP; Nicolas-Chanoine, MH; Pagès, JM; Sotto, A | 1 |
| García-Cano Lizcano, J; Gómez-Ruiz, CJ; Jimeno-Ayllón, C; Martínez-Fernández, R; Morillas-Ariño, J; Pérez-García, JI; Pérez-Sola, Á; Serrano-Sánchez, L | 1 |
| Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G | 1 |
| Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN | 1 |
| Chanawong, A; Charoensri, N; Chetchotisakd, P; Kerdsin, A; Lulitanond, A; Phumsrikaew, W; Rimrang, B; Sribenjalux, P; Wilailuckana, C; Wonglakorn, L | 1 |
| Bouziges, N; Davin-Regli, A; Lavigne, JP; Nicolas-Chanoine, MH; Pagès, JM; Sotto, A | 1 |
| Bollet, C; Bornet, C; Chevalier, J; Chollet, R; Davin-Regli, A; Malléa, M; Pagès, JM | 1 |
| Burgmann, H | 1 |
| Jones, DP; Kink, RJ; Lau, KK | 1 |
| Agrawal, D; Mahapatra, AK | 1 |
| Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M | 1 |
| Bollet, C; La Scola, B; Pagès, JM; Raoult, D; Thiolas, A | 1 |
| Chae, HS; Chang, E; Cho, SG; Kang, CS; Kim, JY; Lee, HK; Park, YJ | 1 |
| Alba, J; Ishii, Y; Kimura, S; Matsushima, Y; Shiroto, K; Watanabe, K; Yamaguchi, K | 1 |
| Deshpande, LM; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Gfröer, S; Knabbe, C; Rahmig, H; Schroeppel, K; Susa, M; Weile, J | 1 |
| Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
| Carmeli, Y; Marchaim, D; Navon-Venezia, S; Schwaber, MJ | 1 |
| Eslami, G; Khorasani, G; Salehifar, E | 1 |
| Neu, HC | 1 |
| Busuttil, RW; McGrattan, MA; Winston, DJ | 1 |
| Lacey, SL; Want, SV | 1 |
| Isbister, WH; Sanea, O | 1 |
| Matsui, S | 1 |
| Kaufmann, ME; Mentis, AF; Tzelepi, E; Tzouvelekis, LS | 1 |
| Casewell, M; Fagan, E; Gimson, A; Philpott-Howard, J; Rolando, N; Sahathevan, M; Westaby, D; Williams, R | 1 |
| Ehrhardt, AF; Sanders, CC; Thomson, KS; Trujillano-Martin, I; Watanakunakorn, C | 1 |
| de Champs, C; Gazuy, N; Guelon, D; Henquell, C; Sirot, D; Sirot, J | 1 |
| Clevenbergh, P; De Gheldre, Y; De Ryck, R; Maes, N; Rost, F; Struelens, MJ; Vincent, JL | 1 |
| Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
| Blondeau, JM; Suter, M; Vaughan, D; Yaschuk, Y | 1 |
| Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B | 1 |
| Bollet, C; Bornet, C; Bosi, C; Davin-Regli, A; Pages, JM | 1 |
| Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
| Hawkey, PM; Li, H; M'Zali, FH; Xiong, J; Ye, H | 1 |
| Laynez, P; Martínez, A; Miguélez, M; Romero, R | 1 |
| Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
| Culver, DH; Gaynes, RP | 1 |
| Bradshaw, MW; Harris, RL; Williams, TW; Zighelboim, J | 1 |
| Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
| Baron, S; Bégué, P; Challier, P; Fontaine, JL; Lasfargues, G; Quinet, B | 1 |
| Frère, JM; Hechler, U; Martin, HH; van den Weghe, M | 1 |
| Aufrant, C; Bompard, Y; Chastel, A; Gantzer, A; Lambert, T; Voinnesson, A | 1 |
| Schliamser, SE | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
2 review(s) available for imipenem, anhydrous and Cronobacter Infections
| Article | Year |
|---|---|
Extended-spectrum beta-lactamases. An overview.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephamycins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Imipenem; Risk Factors | 2001 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
3 trial(s) available for imipenem, anhydrous and Cronobacter Infections
| Article | Year |
|---|---|
Prolonged carriage and potential onward transmission of carbapenemase-producing Enterobacteriaceae in Dutch travelers.
Topics: Adult; Asia; Bacterial Proteins; beta-Lactamases; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Family Characteristics; Feces; Female; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Time Factors; Travel; Young Adult | 2016 |
Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli Infections; Esophageal and Gastric Varices; Esophageal Diseases; Esophagoscopy; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Sclerotherapy; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
Topics: Adult; Aged; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Imipenem; Lung Diseases, Obstructive; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1997 |
117 other study(ies) available for imipenem, anhydrous and Cronobacter Infections
| Article | Year |
|---|---|
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Health Surveys; Hospitals, Private; Molecular Sequence Data; Plasmids | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Latin America; Microbial Sensitivity Tests; Minocycline; North America; Population Surveillance; Tigecycline | 2008 |
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Topics: Australia; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
Spread of OXA-48-encoding plasmid in Turkey and beyond.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence | 2010 |
Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Citrobacter freundii; Enterobacteriaceae Infections; Female; Humans; India; Molecular Sequence Data; Young Adult | 2011 |
Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Risk Factors | 2022 |
The molecular and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae isolated from children in Shanghai, China, 2016-2021.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Child; China; Enterobacteriaceae Infections; Escherichia coli; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny | 2023 |
Activity of imipenem/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Indiana; Microbial Sensitivity Tests | 2019 |
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial R
Topics: Amikacin; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pacific Islands; Population Surveillance | 2020 |
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests | 2020 |
In vitro efficacy of imipenem-relebactam and cefepime-AAI101 against a global collection of ESBL-positive and carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cefepime; Drug Combinations; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Tazobactam; Triazoles | 2020 |
Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Citrobacter freundii; DNA, Bacterial; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Imipenem; Japan; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Prevalence | 2020 |
Rapid detection of extended-spectrum β-Lactamases producers in Enterobacteriaceae using a calorimetry approach.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Calorimetry; Cefotaxime; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2021 |
Rapid detection method of carbapenemase-producing Enterobacteriaceae by MALDI-TOF MS with imipenem/cilastatin (KB) disc and zinc sulfate solution.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cilastatin, Imipenem Drug Combination; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Zinc Sulfate | 2021 |
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype | 2020 |
In vitro activity of imipenem-relebactam against various resistance phenotypes/genotypes of Enterobacterales and Pseudomonas aeruginosa isolated from patients across Canada as part of the CANWARD study, 2016-2019.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Canada; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Imipenem; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cyclooctanes; Drug Discovery; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2017 |
High prevalence of non-clonal imipenem-nonsusceptible Enterobacter spp. isolates in Korea and their association with porin down-regulation.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Down-Regulation; Enterobacter; Enterobacteriaceae Infections; Genotype; Humans; Imipenem; Molecular Typing; Porins; Prevalence; Real-Time Polymerase Chain Reaction; Republic of Korea; Tertiary Care Centers | 2017 |
Susceptibility of Imipenem-Susceptible but Meropenem-Resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests | 2017 |
A novel GoldNano Carb test for rapid phenotypic detection of carbapenemases, particularly OXA type, in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Colorimetry; Enterobacteriaceae; Enterobacteriaceae Infections; Gold; Humans; Imipenem; Metal Nanoparticles; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Pseudomonas aeruginosa; Sensitivity and Specificity | 2017 |
Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Imipenem; Pseudomonas Infections | 2017 |
Comparison of Two Phenotypic Algorithms To Detect Carbapenemase-Producing Enterobacteriaceae.
Topics: Algorithms; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acids; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Imipenem; Penicillins; Ticarcillin | 2017 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Indiana; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Sisomicin | 2017 |
Performance evaluation of BD Phoenix™, an automated microbiology system, for the screening of IMP-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; Carbapenems; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Inosine Monophosphate; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2018 |
Prevalence of class 1 integrons and plasmid-mediated qnr-genes among Enterobacter isolates obtained from hospitalized patients in Ahvaz, Iran.
Topics: Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Fluoroquinolones; Genes, Bacterial; Humans; Imipenem; Integrons; Iran; Meropenem; Microbial Sensitivity Tests; Plasmids; Thienamycins | 2017 |
Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Tunisia | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
Establishment of a dual-wavelength spectrophotometric method for analysing and detecting carbapenemase-producing Enterobacteriaceae.
Topics: Absorption, Physicochemical; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Hydrolysis; Imipenem; Meropenem; ROC Curve; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Statistics, Nonparametric | 2018 |
Activity of Imipenem-Relebactam and Comparator Agents against Genetically Characterized Isolates of Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Drug Combinations; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Tertiary Care Centers; United States | 2019 |
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections | 2013 |
Lack of evidence so far for carbapenemase-producing Enterobacteriaceae in food-producing animals in Switzerland.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cattle; Cattle Diseases; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Imipenem; Microbial Sensitivity Tests; Poultry; Poultry Diseases; Sheep; Sheep Diseases; Swine; Swine Diseases; Switzerland | 2013 |
Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Imipenem; Infection Control; Inosine Monophosphate; Japan; Male; Meropenem; Middle Aged; Phylogeny; R Factors; Retrospective Studies; Risk Factors; Tertiary Healthcare; Thienamycins | 2014 |
Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Imipenem; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Substrate Specificity | 2014 |
Rapid, sensitive and specific detection of OXA-48-like-producing Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Topics: Anti-Bacterial Agents; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2014 |
Imipenem heteroresistance: high prevalence among Enterobacteriaceae Klebsiella pneumoniae carbapenemase producers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae Infections; Escherichia coli; Genetic Variation; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Prevalence | 2015 |
First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Quinolones; Thienamycins | 2015 |
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins | 2014 |
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Taiwan; Thienamycins | 2015 |
Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloxacillin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2015 |
[Emphysematous cystitis: Report of one case].
Topics: Cystitis; Dysuria; Emphysema; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged; Treatment Outcome; Urinary Incontinence, Urge | 2015 |
In Vivo Evolution of Bacterial Resistance in Two Cases of Enterobacter aerogenes Infections during Treatment with Imipenem.
Topics: Anti-Bacterial Agents; Cell Membrane Permeability; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Evolution, Molecular; Genome, Bacterial; Humans; Imipenem; Molecular Sequence Data; Sequence Analysis, DNA | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
Topics: Animals; Anti-Bacterial Agents; China; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Imipenem; Larva; Lepidoptera; Microbial Sensitivity Tests; Microbial Viability; Models, Animal; Time Factors | 2018 |
Modification and evaluation of the Carba NP test by use of paper strip for simple and rapid detection of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Assays; Humans; Imipenem; Phenotype; Polymerase Chain Reaction; Pseudomonas; Reagent Strips | 2016 |
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Laboratory investigation of a suspected outbreak caused by Providencia stuartii with intermediate resistance to imipenem at a long-term care facility.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Disease Outbreaks; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Genotype; Humans; Imipenem; Long-Term Care; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Nursing Homes; Plasmids; Providencia | 2018 |
Rapid direct detection of carbapenemase-producing Enterobacteriaceae in clinical urine samples by MALDI-TOF MS analysis.
Topics: Automation, Laboratory; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Flow Cytometry; Germany; Humans; Imipenem; Polymerase Chain Reaction; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Urine | 2017 |
Rapid discrimination of bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Imipenem; Japan; Multiplex Polymerase Chain Reaction; Mutation | 2017 |
Invitro activity of imipenem-relebactam against gram-negative bacilli isolated from patients with lower respiratory tract infections in the United States in 2015 - Results from the SMART global surveillance program.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2017 |
In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
Topics: Adult; Amino Acid Sequence; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Fatal Outcome; Humans; Imipenem; Liver Transplantation; Male; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Thienamycins | 2008 |
Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.
Topics: Anti-Infective Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Imipenem; Longitudinal Studies; Microbial Sensitivity Tests; Population Surveillance | 2010 |
[Evolution of Enterobacteriaceae resistance to antibiotics in Reunion Island: emergence of extended-spectrum beta-lactamases].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporinase; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Imipenem; Retrospective Studies; Reunion; Substrate Specificity | 2010 |
Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Humans; Imipenem; Israel; Meropenem; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Thienamycins; Tigecycline; United States | 2010 |
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins | 2010 |
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Hydrocephalus; Iatrogenic Disease; Imipenem; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Muscle Hypotonia; Seizures; Serratia Infections; Serratia marcescens; Spinal Puncture; Subdural Effusion; Tunisia | 2011 |
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Citrobacter freundii; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins | 2011 |
Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Color; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Polymerase Chain Reaction; Predictive Value of Tests; Rectum | 2011 |
Imipenem disc for detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Sensitivity and Specificity | 2011 |
Comparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Boronic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity; Thienamycins | 2011 |
Providencia isolates carrying bla (PER-1) and bla (VIM-2) genes: biofilm-forming capacity and biofilm inhibitory concentrations for carbapenem antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Providencia; Thienamycins | 2011 |
Membrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Biological Transport; Caenorhabditis elegans; Cell Membrane; Drug Resistance, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Imipenem; Mutant Proteins; Permeability; Porins; Virulence; Virulence Factors | 2012 |
Liver abscess mimicking colon cancer.
Topics: Aged; Anti-Bacterial Agents; Bacteroides Infections; Cholecystectomy; Citrobacter freundii; Colonic Neoplasms; Colonoscopy; Combined Modality Therapy; Diagnostic Errors; Drainage; Enterobacteriaceae Infections; Fever; Humans; Imipenem; Liver Abscess; Male; Streptococcal Infections; Surgical Wound Infection; Tomography, X-Ray Computed; Ultrasonography, Interventional; Viridans Streptococci | 2011 |
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins | 2012 |
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection | 2012 |
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Thailand | 2012 |
An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; France; Gene Expression Regulation, Bacterial; Hospitals, University; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Porins; Selection, Genetic; Young Adult | 2013 |
Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Genetic Variation; Humans; Imipenem; In Vitro Techniques; Membrane Proteins | 2003 |
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure | 2003 |
Myoclonus associated with intraperitoneal imipenem.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Child, Preschool; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Imipenem; Infusions, Parenteral; Kidney Failure, Chronic; Male; Medication Errors; Meropenem; Myoclonus; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Thienamycins; Tobramycin | 2004 |
Vertically acquired neonatal citrobacter brain abscess - case report and review of the literature.
Topics: Anti-Bacterial Agents; Brain Abscess; Chloramphenicol; Cilastatin; Citrobacter koseri; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Imipenem; Infant, Newborn; Infant, Newborn, Diseases; Infectious Disease Transmission, Vertical; Male; Meningitis, Bacterial; Suction | 2005 |
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.
Topics: Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Evolution, Molecular; Female; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Porins | 2005 |
Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Citrobacter freundii; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Prevalence; Serratia marcescens; Thienamycins | 2005 |
Metallo-beta-lactamase IMP-1 in Providencia rettgeri from two different hospitals in Japan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Humans; Imipenem; Integrons; Japan; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Providencia; Sequence Analysis, DNA | 2005 |
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
Topics: Academic Medical Centers; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Population Surveillance; Serine; Species Specificity; Thienamycins; United States | 2006 |
First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany.
Topics: Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cilastatin; Ciprofloxacin; Citrobacter freundii; Enterobacteriaceae Infections; Female; Germany; Humans; Imipenem; Polymerase Chain Reaction | 2007 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Child; Enterobacter; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Imipenem; Infant, Newborn; Israel; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Treatment Outcome | 2008 |
Profile of microorganisms and antimicrobial resistance at a tertiary care referral burn centre in Iran: emergence of Citrobacter freundii as a common microorganism.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Burns; Child; Ciprofloxacin; Citrobacter freundii; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Imipenem; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas Infections; Wound Infection | 2008 |
Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Enterobacteriaceae Infections; Female; Humans; Imipenem; Male; Middle Aged; Pseudomonas Infections; Staphylococcal Infections; Thienamycins | 1984 |
An outbreak of Enterobacter cloacae associated with contamination of a blood gas machine.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood Gas Analysis; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Thienamycins | 1995 |
Psoas abscess following ileo-anal pouch surgery.
Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Male; Proctocolectomy, Restorative; Psoas Abscess | 1995 |
[A case of severe pneumonia in an elderly man, caused by Citrobacter freundii suspected to have a low susceptibility to imipenem/cilastatin sodium].
Topics: Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Citrobacter freundii; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Male; Pneumonia, Bacterial | 1994 |
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
Topics: Aged; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Mutation | 1994 |
Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
Topics: Aged; Cefoxitin; Cilastatin; Diagnosis, Differential; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male | 1993 |
Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
Topics: Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; beta-Lactamases; Cephalosporinase; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 1993 |
Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Disease Outbreaks; Drug Resistance, Multiple; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Male | 1997 |
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins | 1998 |
In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Haemophilus; Humans; Imipenem; Inhibitory Concentration 50; Microbial Sensitivity Tests; Moraxella; Pseudomonas; Respiratory Tract Infections; Staphylococcus; Streptococcus; Ticarcillin; Urinary Tract Infections | 1999 |
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris | 1999 |
Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
Topics: Bacterial Typing Techniques; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Fatal Outcome; France; Humans; Imipenem; Male; Microbial Sensitivity Tests; Thienamycins; Trachea; Urine | 2000 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
Occurrence of a new metallo-beta-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China.
Topics: Adult; Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; China; Citrobacter; Conjugation, Genetic; Enterobacteriaceae Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Thienamycins | 2001 |
[Pacemaker-cable endocarditis and spondylodiscitis caused by Citrobacter koseri. Conservative treatment].
Topics: Aged; Bacteremia; Cefotaxime; Citrobacter; Discitis; Drug Therapy, Combination; Electrodes, Implanted; Endocarditis, Bacterial; Enterobacteriaceae Infections; Equipment Contamination; Humans; Imipenem; Lumbar Vertebrae; Male; Pacemaker, Artificial; Sacrum; Tobramycin | 2001 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |
Resistance to imipenem among selected gram-negative bacilli in the United States.
Topics: Ceftazidime; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Logistic Models; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 1992 |
Successful medical management of a patient with multiple hepatic abscesses due to Edwardsiella tarda.
Topics: Adult; Ceftriaxone; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Imipenem; Liver Abscess; Male | 1992 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
[Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Imipenem; Infant, Newborn; Male; Pseudomonas Infections; Serratia | 1989 |
Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cell Membrane; Cell Membrane Permeability; Drug Resistance, Microbial; Enterobacteriaceae Infections; Enzyme Induction; Gene Expression Regulation, Bacterial; Imipenem; Kinetics; Serratia marcescens | 1989 |
[Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cilastatin; Cyclopropanes; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Sepsis; Thienamycins | 1988 |
Neurotoxicity of beta-lactam antibiotics. Experimental kinetic and neurophysiological studies.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Carbapenems; Cilastatin; Drug Interactions; Electroencephalography; Enterobacteriaceae Infections; Female; Hippocampus; Imipenem; Male; Meningitis; Penicillin G; Rabbits; Rats; Rats, Inbred Strains; Seizures; Thiopental; Tissue Distribution; Uremia | 1988 |
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins | 1986 |